Merck receives complete response letter from the U.S. FDA for Tecos study with sitagliptin
admin 10th April 2017 Uncategorised 0Merck
More: Merck receives complete response letter from the U.S. FDA for Tecos study with sitagliptin
Source: MDlinx
© 1994 - 2025 B.M. Pharmaceuticals